SiVEC Biotechnologies

PhotonPharma, Inc., located in Fort Collins, CO, is focused on developing innovative therapies for solid tumor cancers, specifically through their autologous therapy, Innocell. Currently, they are conducting a Phase 1 clinical study to evaluate the safety and immunogenicity of the Innocell autologous vaccine in patients with recurrent epithelial ovarian cancer. With ovarian cancer presenting significant challenges, including nearly 19,880 new cases and 12,810 deaths annually in the U.S., PhotonPharma aims to enhance treatment options by potentially delaying disease progression in conjunction with existing therapies. Their research is dedicated to improving outcomes for patients facing solid tumor malignancies. Generated from the website

GT Molecular, LLC in Fort Collins offers a cutting-edge Digital PCR Testing Service for the SARS-CoV-2 COVID-19 virus, providing ultrasensitive and fast results with high accuracy. Their comprehensive service includes analysis software and molecular assays for cancer and pathogen detection, genotyping, and gene expression. With a focus on precision and efficiency, GT Molecular, LLC is dedicated to delivering top-notch molecular testing solutions for a variety of applications. Their advanced technology and expertise make them a trusted partner for accurate and reliable testing services. Generated from their website's infomation

Biotect Services, Inc is a contract research organization (CRO) specialty laboratory based in Fort Collins, CO. They specialize in the preclinical assessment of oncology and CNS drug candidates, offering tailored model design and efficacy testing in 2D and 3D in-vitro cell-culture models. With a mission to improve patient outcomes, Biotect Services combines cutting-edge and traditional laboratory-based technologies to design and implement assays that are relatable to patient outcomes in clinical trials. Their professional team works closely with non-profit organizations, pharmaceutical companies, biotechnology companies, government agencies, and universities to advance promising therapeutics from the bench to the clinic.Generated from the website